Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Bioorganic Chemistry|July 2, 2022
From EGFR kinase inhibitors to anti-inflammatory drugs: Optimization and biological evaluation of (4-(phenylamino)quinazolinyl)-phenylthiourea derivatives as novel NF-κB inhibitorsReem A Wagdy, Po-Jen Chen, Mostafa M Hamed, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 28, 2020
Cystobactamid 507: Concise Synthesis, Mode of Action, and Optimization toward More Potent AntibioticsWalid A M Elgaher, Mostafa M Hamed, Sascha Baumann, et al.
European Journal of Medicinal Chemistry|November 20, 2024
Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffoldHend Khalifa, Ahmed K ElHady, Ting Liu, et al.
Archiv Der Pharmazie|February 2, 2024
Development and evaluation of 2,4-disubstituted-5-aryl pyrimidine derivatives as antibacterial agentsHend Khalifa, Sari Rasheed, Jörg Haupenthal, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2022
Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid partSarah H Megahed, Sari Rasheed, Jennifer Herrmann, et al.
Molecules (Basel, Switzerland)|August 27, 2021
Expanding the Myxochelin Natural Product Family by Nicotinic Acid Containing CongenersNicolas A Frank, Márió Széles, Sergi H Akone, et al.
Bioorganic Chemistry|October 26, 2021
Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Optimization of the 2,4-substituentsDina Aboushady, Sari S Rasheed, Jennifer Herrmann, et al.
JACS Au|March 28, 2025
Positive Charge in an Antimalarial Compound Unlocks Broad-Spectrum Antibacterial ActivityMaria Braun-Cornejo, Mitchell Platteschorre, Vincent de Vries, et al.
European Journal of Medicinal Chemistry|February 13, 2025
From Dyrk1A inhibitors to a novel class of antiviral agents: Targeting Enterovirus EV-A71 with 2-aryl-substituted thiophene scaffoldsParthiena M Keddis, Tuong-Khanh My Tu, Hugo Scherer, et al.
Journal of Medicinal Chemistry|June 6, 2026
Hit-to-Lead Optimization of Energy-Coupling Factor (ECF) Transporter Inhibitors as Novel AntibioticIoulia Exapicheidou, Aleksei Tsarenko, Lena Zeller, et al.
Pageof 5